Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jaymala Patel"'
Autor:
Qi Long, Naomi B. Haas, Michael J. LaRiviere, Eun Jeong Min, Yauheniya Cherkas, Jeremy O. Jones, Sumanta K. Pal, Erica L. Carpenter, David J. Vaughn, Samantha L. Savitch, Taylor A. Black, Stephanie S. Yee, Kathryn E. Wellen, Brad Foulk, Miaoling He, Thomas H. Buckingham, Steven Gross, Ravi K. Amaravadi, Denis Smirnov, Jaymala Patel, Karl Calara-Nielsen, Krishna J. Majmundar
Publikováno v:
Prostate Cancer and Prostatic Diseases. 24:448-456
Precision medicine approaches for managing patients with metastatic castrate-resistant prostate cancer (mCRPC) are lacking. Non-invasive approaches for molecular monitoring of disease are urgently needed, especially for patients suffering from bone m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faea5c7157ba1adee214ff63bacccbfa
https://doi.org/10.1038/s41391-020-00295-z
https://doi.org/10.1038/s41391-020-00295-z
Autor:
Yulia Nefedova, Ayumi Hashimoto, Denis Smirnov, Dmitry I. Gabrilovich, Jaymala Patel, Emilio Sanseviero, Charles Mulligan, Alessandra De Leo, Vipul Bhargava, Evgeniy Eruslanov, Gregory A. Masters, Razvan Cristescu, Patrick Wilkinson, Manuel A. Sepulveda, Filippo Veglia, Andrey Loboda, Andrew V. Kossenkov, Evgenii N. Tcyganov, Harsh Dweep, Brian Nam, Sunil Singhal
Publikováno v:
The Journal of Experimental Medicine
Veglia et al. characterize the heterogeneity of polymorphonuclear neutrophils (PMNs) in the tumor microenvironment, spleen, and peripheral blood. The identification of neutrophil populations with potent immune suppressive activity opens selective tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a3dd2b8f1a8855e4b956149a7520a0c
http://europepmc.org/articles/PMC7879582
http://europepmc.org/articles/PMC7879582
Autor:
Peter Ulz, Ellen Heitzer, Julie Waldispuehl-Geigl, Denis Smirnov, Jaymala Patel, Ricarda Graf, Mitchell E. Gross, Michael R. Speicher, Thomas Bauernhofer, Weimin Li, Jelena Belic, Jochen B. Geigl, Samantha Perakis, Yauheniya Cherkas, Michael Gormley
Publikováno v:
International Journal of Cancer. 143:1236-1248
In patients with metastatic castrate-resistant prostate cancer (mCRPC), circulating tumor DNA (ctDNA) analysis offers novel opportunities for the development of non-invasive biomarkers informative of treatment response with novel agents targeting the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a036d2582127f7ef4a8d1798cb3ffd07
https://doi.org/10.1002/ijc.31397
https://doi.org/10.1002/ijc.31397
Autor:
Jeremy O. Jones, Sumanta K. Pal, Denis Smirnov, Brad Foulk, Jaymala Patel, Vipul Bhargava, Miaoling He, Katherine Kraft, Przemyslaw Twardowski, Marcin Kortylewski
Publikováno v:
Cancer. 124:1216-1224
Background Two androgen receptor (AR)-targeted therapies, enzalutamide and abiraterone acetate plus prednisone (abiraterone), have been approved for the treatment of metastatic castration-resistant prostate cancer (CRPC). Many patients respond to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc521854c04fa405e0dc05daeb147c6f
https://doi.org/10.1002/cncr.31161
https://doi.org/10.1002/cncr.31161
Autor:
Jelena, Belic, Ricarda, Graf, Thomas, Bauernhofer, Yauheniya, Cherkas, Peter, Ulz, Julie, Waldispuehl-Geigl, Samantha, Perakis, Michael, Gormley, Jaymala, Patel, Weimin, Li, Jochen B, Geigl, Denis, Smirnov, Ellen, Heitzer, Mitchell, Gross, Michael R, Speicher
Publikováno v:
International Journal of Cancer
In patients with metastatic castrate‐resistant prostate cancer (mCRPC), circulating tumor DNA (ctDNA) analysis offers novel opportunities for the development of non‐invasive biomarkers informative of treatment response with novel agents targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c36e12559a1a3007484a33638a26de2a
https://pubmed.ncbi.nlm.nih.gov/29574703
https://pubmed.ncbi.nlm.nih.gov/29574703
Autor:
Sumanta Kumar, Pal, Jaymala, Patel, Miaoling, He, Brad, Foulk, Katherine, Kraft, Denis A, Smirnov, Przemyslaw, Twardowski, Marcin, Kortylewski, Vipul, Bhargava, Jeremy O, Jones
Publikováno v:
Cancer. 124(6)
Two androgen receptor (AR)-targeted therapies, enzalutamide and abiraterone acetate plus prednisone (abiraterone), have been approved for the treatment of metastatic castration-resistant prostate cancer (CRPC). Many patients respond to these agents,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3804ff216da9818ef1116eadb74aac1
https://pubmed.ncbi.nlm.nih.gov/29359738
https://pubmed.ncbi.nlm.nih.gov/29359738
Autor:
Brad Foulk, Jeremy O. Jones, Stephanie S. Yee, Ravi K. Amaravadi, Naomi B. Haas, Yauheniya Cherkas, Krishna S. Majmundar, Samantha L. Savitch, Denis Smirnov, Jaymala Patel, Michael J. LaRiviere, Thomas H. Buckingham, Sumanta K. Pal, Erica L. Carpenter, David J. Vaughn, Karl Nielsen
Publikováno v:
Journal of Clinical Oncology. 37:e16529-e16529
e16529 Background: Prostate cancer is the most common cancer in men in the U.S., with 30% 5-year overall survival (OS) for patients (pts) with metastases. To take a precision medicine approach to the management of metastatic castrate-resistant prosta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c52dad26f7addb90401f89db8a70d707
https://doi.org/10.1200/jco.2019.37.15_suppl.e16529
https://doi.org/10.1200/jco.2019.37.15_suppl.e16529
Autor:
Ellen Heitzer, Mitchell E. Gross, Weimin Li, Jochen B. Geigl, Michael Gormley, Jelena Belic, Samantha Perakis, Michael R. Speicher, Ulz Peter, Denis Smirnov, Yauheniya Cherkas, Jaymala Patel, Thomas Bauernhofer, Julie Waldispuehl-Geigl, Ricarda Graf
Publikováno v:
Cancer Research. 78:2959-2959
Background: Recent progress in the analysis of cell-free circulating tumor DNA (ctDNA) now allows for the monitoring of tumor genomes by noninvasive means. The introduction of abiraterone and enzalutamide for the treatment of metastatic castration-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d226963a6ba14b933f2eee8d49cf5bb6
https://doi.org/10.1158/1538-7445.am2018-2959
https://doi.org/10.1158/1538-7445.am2018-2959
Autor:
Nazli Dizman, Jeremy O. Jones, JoAnn Hsu, Brad Foulk, Sumanta K. Pal, Miaoling He, Vipul Bhargava, Przemyslaw Twardowski, Marcin Kortylewski, Denis Smirnov, Jaymala Patel
Publikováno v:
Annals of Oncology. 28:v586
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08081d0d8a7c3348086f0a3908fb9e79
https://doi.org/10.1093/annonc/mdx390.042
https://doi.org/10.1093/annonc/mdx390.042
Autor:
Shibu Thomas, Dong Shen, Deborah Ricci, Yashoda Rajpurohit, Michael Gormley, Denis Smirnov, Jaymala Patel
Publikováno v:
Cancer Research. 77:2755-2755
Approximately 28,000 men die from prostate cancer in the US each year. Predictive biomarkers can provide patient risk assessment to enable therapeutic decision making. Compared to tumor, blood based liquid biopsies offer greater flexibility for nonin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d714631a606d5adb446d65f615078e55
https://doi.org/10.1158/1538-7445.am2017-2755
https://doi.org/10.1158/1538-7445.am2017-2755